ProfileGDS5822 / ILMN_2829129
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 56% 32% 53% 34% 27% 63% 62% 56% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 124.956
GSM1276600PDAC Late Ablation Control 217.932
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 120.853
GSM1276603PDAC Late Ablation 216.534
GSM1276604PDAC Late Ablation 314.727
GSM1303940PDAC Late Ablation_anti-CTLA4 131.663
GSM1303941PDAC Late Ablation_anti-CTLA4 23962
GSM1303942PDAC Late Ablation_anti-CTLA4 331.556